HEATHER BUCKHEISTER: Open Payments
NPI 1942792973 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,441 in 112 payments from 23 companies in 2025. Trend: 2023 $294 · 2024 $1,889 · 2025 $2,441
Food & beverage: $2,441
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $290 |
| GlaxoSmithKline, LLC. | 20 | $284 |
| Regeneron Healthcare Solutions, Inc. | 8 | $247 |
| Verona Pharma, Inc. | 13 | $208 |
| GENZYME CORPORATION | 8 | $204 |
| ANI Pharmaceuticals, Inc. | 7 | $204 |
| Viatris Specialty LLC | 9 | $198 |
| Mallinckrodt Hospital Products Inc. | 6 | $127 |
| Grifols USA, LLC | 5 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
Products named: DUPIXENT, TEZSPIRE, Ohtuvayre, PURIFIED CORTROPHIN GEL, YUPELRI, TRELEGY ELLIPTA, ACTHAR, Prolastin-C Liquid.
Industry payments across MS — which companies pay providers there.
